PortalPublikationenProstate-specific antigen improves the ability of clinical s...

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

Standard

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. / Chun, Felix; Briganti, Alberto; Gallina, Andrea; Hutterer, Georg C; Shariat, Shahrokh F; Antebie, Elie; Walz, Jochen; Roehrborn, Claus G; Salonia, Andrea; Rigatti, Patrizio; Saad, Fred; Huland, Hartwig; Montorsi, Francesco; Graefen, Markus; Karakiewicz, Pierre I.

in: EUR UROL, Jahrgang 52, Nr. 4, 4, 2007, S. 1067-1074.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Chun, F, Briganti, A, Gallina, A, Hutterer, GC, Shariat, SF, Antebie, E, Walz, J, Roehrborn, CG, Salonia, A, Rigatti, P, Saad, F, Huland, H, Montorsi, F, Graefen, M & Karakiewicz, PI 2007, 'Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.', EUR UROL, Jg. 52, Nr. 4, 4, S. 1067-1074. <http://www.ncbi.nlm.nih.gov/pubmed/17383807?dopt=Citation>

APA

Chun, F., Briganti, A., Gallina, A., Hutterer, G. C., Shariat, S. F., Antebie, E., Walz, J., Roehrborn, C. G., Salonia, A., Rigatti, P., Saad, F., Huland, H., Montorsi, F., Graefen, M., & Karakiewicz, P. I. (2007). Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. EUR UROL, 52(4), 1067-1074. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17383807?dopt=Citation

Vancouver

Chun F, Briganti A, Gallina A, Hutterer GC, Shariat SF, Antebie E et al. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. EUR UROL. 2007;52(4):1067-1074. 4.

Bibtex

@article{013dacd4b1b141b196fe762eaf3b78c6,
title = "Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.",
abstract = "OBJECTIVES: The contemporary ability of prostate-specific antigen (PSA) to predict pathologic stage in men with localized prostate cancer was recently questioned. METHODS: We quantified the added value related to the addition of pretreatment PSA to established pathologic stage predictors (namely clinical stage and biopsy Gleason sum) in 5921 consecutive radical prostatectomy (RP) patients. Univariable and multivariable logistic regression analyses predicting pathologic stage (extracapsular extension [ECE], seminal vesicle invasion [SVI], lymph node invasion [LNI], and organ-confined disease [OC]) were stratified according to four time quartiles. The gain in predictive accuracy (PA) related to the inclusion of PSA to multivariable models was quantified by using the area under the curve method. RESULTS: Temporal analyses showed a decrease in PSA levels over the study years (p",
author = "Felix Chun and Alberto Briganti and Andrea Gallina and Hutterer, {Georg C} and Shariat, {Shahrokh F} and Elie Antebie and Jochen Walz and Roehrborn, {Claus G} and Andrea Salonia and Patrizio Rigatti and Fred Saad and Hartwig Huland and Francesco Montorsi and Markus Graefen and Karakiewicz, {Pierre I}",
year = "2007",
language = "Deutsch",
volume = "52",
pages = "1067--1074",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

AU - Chun, Felix

AU - Briganti, Alberto

AU - Gallina, Andrea

AU - Hutterer, Georg C

AU - Shariat, Shahrokh F

AU - Antebie, Elie

AU - Walz, Jochen

AU - Roehrborn, Claus G

AU - Salonia, Andrea

AU - Rigatti, Patrizio

AU - Saad, Fred

AU - Huland, Hartwig

AU - Montorsi, Francesco

AU - Graefen, Markus

AU - Karakiewicz, Pierre I

PY - 2007

Y1 - 2007

N2 - OBJECTIVES: The contemporary ability of prostate-specific antigen (PSA) to predict pathologic stage in men with localized prostate cancer was recently questioned. METHODS: We quantified the added value related to the addition of pretreatment PSA to established pathologic stage predictors (namely clinical stage and biopsy Gleason sum) in 5921 consecutive radical prostatectomy (RP) patients. Univariable and multivariable logistic regression analyses predicting pathologic stage (extracapsular extension [ECE], seminal vesicle invasion [SVI], lymph node invasion [LNI], and organ-confined disease [OC]) were stratified according to four time quartiles. The gain in predictive accuracy (PA) related to the inclusion of PSA to multivariable models was quantified by using the area under the curve method. RESULTS: Temporal analyses showed a decrease in PSA levels over the study years (p

AB - OBJECTIVES: The contemporary ability of prostate-specific antigen (PSA) to predict pathologic stage in men with localized prostate cancer was recently questioned. METHODS: We quantified the added value related to the addition of pretreatment PSA to established pathologic stage predictors (namely clinical stage and biopsy Gleason sum) in 5921 consecutive radical prostatectomy (RP) patients. Univariable and multivariable logistic regression analyses predicting pathologic stage (extracapsular extension [ECE], seminal vesicle invasion [SVI], lymph node invasion [LNI], and organ-confined disease [OC]) were stratified according to four time quartiles. The gain in predictive accuracy (PA) related to the inclusion of PSA to multivariable models was quantified by using the area under the curve method. RESULTS: Temporal analyses showed a decrease in PSA levels over the study years (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 52

SP - 1067

EP - 1074

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 4

M1 - 4

ER -